<rss version="2.0">
  <channel>
    <title>Generic Drugs Press Releases from SmartBrief</title>
    <link>http://www.smartbrief.com/news/FDLI/pressReleases.jsp?sb_code=RSS&amp;industry=Generic%20Drugs</link>
    <description>Generic Drugs Press Releases from SmartBrief</description>
    <item>
      <title>Lannett Reauthorizes Stock Repurchase Program</title>
      <link><![CDATA[http://www.smartbrief.com/news/FDLI/industryBW-detail.jsp?id=5F572778-D954-4F22-934E-08ED72419230&amp;sb_code=RSS&amp;i=Generic%20Drugs]]></link>
      <description>Lannett Company, Inc. (NYSE AMEX: LCI) today announced that its Board of Directors has approved a reauthorization of the stock repurchase program. Under the program, the company is authorized to repurchase up to $5 million of Lannett?s outstanding co...</description>
      <pubDate>Fri, 20 Nov 2009 14:04:45 CST</pubDate>
    </item>
    <item>
      <title>Impax Laboratories Drives Stronger Performance with IBM Business Analytics</title>
      <link><![CDATA[http://www.smartbrief.com/news/FDLI/industryPR-detail.jsp?id=19BFCD18-E06A-45C9-B6E8-C7643A6ABBD5&amp;sb_code=RSS&amp;i=Generic%20Drugs]]></link>
      <description>ARMONK, N.Y., Nov. 20 /PRNewswire-FirstCall/ -- IBM </description>
      <pubDate>Fri, 20 Nov 2009 08:04:45 CST</pubDate>
    </item>
  </channel>
</rss>
